Article Results (Showing 1 - 7 of 7) RSS Alert
-
Credibility of scientists: industry versus public interest
In their article "Assessing the Reliability and Credibility of Industry Science and Scientists," Barrow and Conrad (2006) demonstrated a...
Environmental Health Perspectives, 03/01/06 by Merrill Goozner · More from publication -
Doctored bills.(LETTERS)(Letter to the Editor)
According to the September Index, the cost of developing a new drug was $868 million in 1997 and $1.43 billion in 2004. An interesting follow-up...
Harper's Magazine, 12/01/05 by Goozner, Merrill · More from publication -
Study on failures to disclose conflicts of interest in Environmental Health Perspectives
The Center for Science in the Public Interest (CSPI) recently investigated conflict of interest disclosures in a cross-section of leading...
Environmental Health Perspectives, 10/01/04 by Merrill Goozner · More from publication -
Trial and error: why we should drive the drug industry out of the clinical test business
The Truth About the Drug Companies: How They Deceive Us and What To Do About It By Marcia Angell Random House, $24.95 The Truth About the Drug...
Washington Monthly, 10/01/04 by Merrill Goozner · More from publication -
Drug antics
IN A NATION WHERE MOST people worship business--and where business controls politics--it often takes a tragedy to convince lawmakers to protect the...
Washington Monthly, 06/01/03 by Merrill Goozner · More from publication -
The right drug Rx. (Comment).(Medicare + Choice plans)
With a doctor in charge of the Senate, compassionate conservatism is well positioned to run roughshod over the issue that traditionally worked...
Nation, The, 01/27/03 by Goozner, Merrill · More from publication -
GREENSPAN: The Man Behind Money. - Review - book review
GREENSPAN: The MAN Behind Money by Justin Martin Perseus Book Group, $28.00 GREENSPAN: The MAN Behind Money by Justin Martin Perseus Book Group,...
Washington Monthly, 11/01/00 by Merrill Goozner · More from publication
